Viewing Study NCT02338050


Ignite Creation Date: 2025-12-24 @ 4:55 PM
Ignite Modification Date: 2026-05-01 @ 11:33 PM
Study NCT ID: NCT02338050
Status: TERMINATED
Last Update Posted: 2015-09-16
First Post: 2015-01-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Moxetumomab Pasudotox (CAT-8015, HA22) in Children With B-lineage Acute Lymphoblastic Leukemia and Minimal Residual Disease Prior to Allogeneic Hematopoietic Stem Cell Transplantation
Sponsor: Center for International Blood and Marrow Transplant Research
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Acute Lymphoblastic Leukemia (ALL) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ALL View
None Moxetumomab Pasudotox View
None Moxe View
None CAT-8015, HA22 View